Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex expands with new Paris office

Sophie Guillaume and Patrick Larcier to lead the new branch

PharmaLexPharmaceutical service provider PharmaLex has expanded its European operations with the launch of a new office in Paris, France.

The firm, which merged with YES Pharma Services in October last year, will now offer its pharmacovigilance and regulatory affairs consulting expertise to the French pharmaceutical industry and looks to grow its local presence in the area.

Dr Thomas Dobmeyer, co-chief executive officer of PharmaLex, said: “For the pharmaceutical industry, France plays a significant role on an international level.

“It is of great importance and strategic interest to be able to service this highly thriving market.”

Leading the new subsidiary are Sophie Guillaume and Patrick Larcier, as general manager and senior director for drug development and vigilance, respectively.

Guillaume commented: “Together with Patrick Larcier, I am excited to have planted the seed for PharmaLex in France.

“We will grow our local presence in close cooperation with our international colleagues, allowing us to provide highest standards of quality of all services from the very beginning.”

Article by
Rebecca Clifford

10th October 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...

Infographics